Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Jan 2026 for LAKEFRONT BIOTHERAPEUTICS, €3,950.
Filing timeline
BuySaleJohnston Neil
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -13.9%Entry 28.42 · Close at T+90 24.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Johnston Neil: trading record in brief
Only one filing by Johnston Neil is known so far (26 January 2026): an open-market purchase, €3,950, in Lakefront Biotherapeutics. That is too little to draw conclusions. Source: insider filings from FSMA. Past trades are no guide to future returns.
Companies and markets linked to Johnston Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 137 shares@ €28.84100.0% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-10Canonical exit: 22 Apr 2026 (T+90)
1 of 1 declaration